Physician profile
Matthew A Grossman
NPI 1063618908
$7,023.85
in general payments reported to CMS, 2019-2025
39 companies · $1,758 in 2025
The $1,758 reported for 2025 was more than what 76% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $878 · 2020: $345 · 2021: $765 · 2022: $714 · 2023: $1,294 · 2024: $1,269 · 2025: $1,758.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,321.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,320.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,358.31 | 2019-2025 | Apollo Esg System, Nxt Tissue Helix Pro, Wallflex Duodenal |
| Abbvie INC. | $954.69 | 2019-2025 | |
| Olympus America INC. | $697.58 | 2019-2023 | Visiglide, Evis Exera Lll Colonovideoscope |
| Medtronic, INC. | $314.74 | 2021-2025 | Nexpowder, Gi Genius |
| Gilead Sciences, INC. | $313.48 | 2023-2025 | Livdelzi |
| 3-D Matrix, INC. | $284.12 | 2025 | |
| Pfizer INC. | $233.01 | 2023-2025 | |
| Covidien LP | $228.16 | 2019 | |
| Genzyme Corporation | $211.53 | 2025 | |
| Merit Medical Systems INC | $198.75 | 2025 | Esophyx |
| Amgen INC. | $176.37 | 2025 | Evenity, Uplizna |
| Apollo Endosurgery US INC | $176.15 | 2021 | |
| Steris Corporation | $164.17 | 2024-2025 | |
| Janssen Biotech, INC. | $147.32 | 2023-2024 | Stelara |
| Allergan, INC. | $125.00 | 2020 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Grossman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.